JNJ 5207787

Catalog No.: C007B-550041
Mfr. No.: J287095-1mg
Mfr. Name: Aladdin Scientific
Qty/UOM: 1
UOM: EA

Price: $155.60

List Price: $172.88

JNJ-5207787 is a penetrates the blood-brain barrier neuropeptide Y Y2 receptor (Y2) antagonist. It is >:100-fold selective versus human Y1, Y4, and Y5 receptors.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

JNJ-5207787 is a penetrates the blood-brain barrier neuropeptide Y Y2 receptor (Y2) antagonist. It is >100-fold selective versus human Y1, Y4, and Y5 receptors. JNJ-5207787 suppresses the binding of peptide YY with pIC50s of 7.0 and 7.1 for the human Y2 receptor and rat Y2 receptor, respectively.

Specification: Moligand™, ≥95%

Molecular Formula: C32H38N4O2

Molecular Weight: 510.67

PubChem CID: 10324083

Isomeric SMILES: CC(=O)N1CCC2=C1C=C(C=C2)N(C3CCN(CC3)CCC4CCCC4)C(=O)/C=C/C5=CC(=CC=C5)C#N

Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/J287095-SCI_9ca704cf224d5c253e6b58eed846eb7e.pdf

UPC:: 51142558
Condition:: New
Availability:: 4-8 weeks
Weight:: 0.07 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: J287095-1mg
CAS:: 683746-68-1
Product Size:: 1mg

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."